SJSandra Jacobs

Sandra Jacobs

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sandra Jacobs has a total of 154 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    O-mannosylation and protein maturation checkpoints represent therapeutic opportunities in BRAF fusion protein oncogenesis

    by Anna Borgenvik, Sean A. Misek, Daniel Christen, Gloria Kyrila, Alexander Zhang, Sarah Reel, Michelle Boisvert, Kelly Y. Cai, Anna Kovarzin, Hongyu Li, et al.

    Fusions between protein-coding genes are common oncogenic drivers, typically pairing a proto-oncogene with a partner that does not independently drive cancer. In all therapeutically actionable fusions, the proto-oncogene is the drug target, the contributions to oncogenicity of the fusion partner have largely been ignored. We studied the role of BRAF fusion partners and found that they are necessary for transformation. In the setting of KIAA1549::BRAF, the most common fusion protein across brain tumors, we found that KIAA1549 is necessary for oncogenicity of KIAA1549::BRAF and engenders a striking and specific dependency on the protein O-mannosyltransferase complex (POMT1/2). Specifically, we show that genetic silencing or pharmacologic inhibition of POMT1/2 reverses fusion-induced transformation, thereby representing a novel and MAPK-independent therapeutic target. Furthermore, POMT1/2 is required to glycosylate and enable maturation of the K::B fusion protein. These findings represent a proof-of-concept for targeting the partners in oncogenic fusions as a potential cancer therapeutic strategy.


  • Open Access

    From Diagnosis Delay to Targeted Therapy: A Retrospective Study of Pediatric DLGNT with a Comprehensive Literature Review

    by Riccardo De Carli, Viviana Minichini, Laetitia Lebrun, An Van Damme, Christophe Chantrain, Anais Fohn, Sandra Jacobs, Frederik De Smet, Pierre Leblond, Nicolas André, et al.

    Background: Diffuse leptomeningeal glioneuronal tumors (DLGNT) are rare pediatric central nervous system tumors, first recognized in the 2016 WHO classification. Their clinical course is highly heterogeneous, and no international consensus treatment guidelines are currently available. This study aims to describe clinical characteristics, disease evolution, and management strategies for pediatric DLGNT patients, with a focus on aggressive forms. Methods: This retrospective, multicenter, international study (Belgium and France) included pediatric patients diagnosed with DLGNT between 1 February 2016 and 31 December 2024. Clinical, radiological, histopathological, molecular, and therapeutic data were collected. Findings were analyzed and contextualized through an extensive literature review. Results: Eleven patients were enrolled (median age: 8.2 years; median follow-up: 52 months). The median delay between the first MRI and definitive diagnosis was 6.5 months. Symptoms of intracranially elevated pressure were present in 55% of patients. Two-thirds of the patients presented with leptomeningeal dissemination at diagnosis. The primary tumor site could not be identified in two patients. A KIAA1549::BRAF transcript fusion was detected in 82% of cases, and chromosome 1q gain in 38%. All patients underwent surgery at diagnosis. The median number of therapeutic lines was four: 82% received chemotherapy (weekly vinblastine in 55%, vincristine/carboplatin regimen in 45%), 64% received MAPK pathway-targeted therapy, and 18% underwent radiotherapy. Five-year overall survival (OS) was 68.5%, and median progression-free survival (PFS) was 5.3 months after first-line therapy and 16.5 months after the second line. At the end of follow-up, only one patient achieved complete remission, and 78% of survivors presented with persistent neurological deficits. Conclusions: This study underscores the significant diagnostic delay, clinical heterogeneity, and absence of standardized therapeutic approaches in pediatric DLGNT patients. Conventional low-grade glioma chemotherapy constitutes the current treatment backbone, while MAPK pathway-targeted therapies show promising potential. Further studies and the establishment of an international registry are crucial to better characterize aggressive subtypes and optimize management strategies.


  • Open Access

    Gray Matter Volumetry and Cognitive Functioning in Pediatric Posterior Fossa Tumor Survivors

    by Kristien Bullens, Charlotte Sleurs, Jeroen Blommaert, Karen Van Beek, Jurgen Lemiere, Sandra Jacobs

    Background/Objectives: Posterior fossa tumors (PFTs) often require radiotherapy which may damage both cortical and subcortical brain tissue. We examined voxel-based and region-based gray matter volume (GMV) alterations and explored their relation to cognitive functioning. Methods: Using T1-weighted MR imaging, intelligence scores from the Wechsler Adult Intelligence Scale-IV (WAIS-IV), and domain scores for language, learning, and memory, complex attention and cognitive flexibility were investigated in 18 of 21 assessed PFT survivors and 21 matched controls. GMV was quantified with voxel-based and region-based volumetry, compared among groups (controls versus survivors, irradiated versus non-irradiated survivors), and correlated with cognitive performance. Results: Survivors showed reduced GMV in two voxel-based clusters, located in the left occipital fusiform area and the left pallidum. Region-based analyses showed lower GMV in survivors located in subcortical areas, while higher GMV was observed in the left inferior temporal region. Survivors who received craniospinal radiation exhibited reductions in GMV in bilateral thalami, right ventral diencephalon, and central corpus callosum, and higher GMV in the bilateral middle temporal regions. Compared to controls, survivors scored lower for all cognitive domains, except for complex attention and cognitive flexibility. Amongst survivors, the GMV of the bilateral thalami and right ventral diencephalon correlated positively with working memory. Conclusions: Overall, PFT survivors demonstrated both alterations in GMV and cognitive functioning, with the most pronounced GMV deviations found in those treated with craniospinal radiation. Reduced GMV was associated with poorer cognitive performance.

  • Open Access

    Altered structural networks and cognitive functioning in long-term survivors of pediatric brain tumors

    by Kristien Bullens, Charlotte Sleurs, Jeroen Blommaert, Rebeca Alejandra Gavrila Laic, Ahmed Radwan, Laurien De Roeck, Patrick Dupont, Jurgen Lemiere, Sandra Jacobs


  • Open Access

    Reply to Taal et al. Comment on “Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers 2025, 17, 1306”

    by Maria Pia Iasella, Dries Ruttens, Daphne Hompes, Vincent Vandecaveye, Raf Sciot, Christophe Deroose, Thomas Douchy, Thomas Decramer, Sandra Jacobs, Ellen Denayer, et al.

    We would like to sincerely thank Dr

  • Open Access

    Exploring the tumor microenvironment in diffuse intrinsic pontine glioma: immunological insights and therapeutic challenges

    by Bieke Van Den Ende, Matteo Riva, Frederik De Smet, Sandra Jacobs, Esther Hulleman, An Coosemans

    Diffuse intrinsic pontine glioma (DIPG) is a rare and highly aggressive pediatric brain tumor with a median survival of less than 12 months. The tumor arises in the pons, making surgical resection unfeasible and limiting treatment options to palliative radiation, which offers minimal survival benefit. One of the major challenges in treating DIPG is the poorly understood tumor immune microenvironment, which has hindered the development of effective immunotherapies. DIPG tumors are considered to be immunologically cold with limited immune cell infiltration. Recent studies have begun to reveal the complex and heterogeneous immune landscape of DIPG, highlighting distinct immunological subgroups. This review aims to provide a comprehensive overview of the immune landscape of DIPG based on the latest insights, identify research gaps, and suggest potential areas for future investigation to improve treatment outcomes for patients with DIPG.


  • Open Access

    Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour

    by Maria Pia Iasella, Dries Ruttens, Daphne Hompes, Vincent Vandecaveye, Raf Sciot, Christophe Deroose, Thomas Douchy, Thomas Decramer, Sandra Jacobs, Ellen Denayer, et al.

    Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic condition with a birth incidence of one in 2000 to one in 3000


  • A systematic review of interventions for neurocognitive dysfunctions in patients and survivors of a pediatric brain tumor

    by Kristien Bullens, Charlotte Sleurs, Jeroen Blommaert, Jurgen Lemiere, Sandra Jacobs

    Due to a high burden of neurocognitive impairment on patients with a pediatric brain tumor, interventions mitigating these symptoms are highly needed. Currently, evidence on the efficacy and feasibility of such interventions remains scarce. A systematic literature study was performed based on four different databases (PubMed, Web of Science Core Collection, Embase, and PsycArticles). Resulting articles ( n = 2232) were screened based on title and abstract, and full text. We included 28 articles, investigating cognitive effects of either a lifestyle intervention ( n = 6), a cognitive training ( n = 15), or pharmacological intervention ( n = 7). The most frequently studied interventions were the Cogmed and methylphenidate. Most interventions showed short‐term efficacy. Fewer interventions also showed long‐term maintenance of positive results. Despite positive trends of these interventions, results are heterogeneous, suggesting relatively limited efficacy of existing interventions and more potential of more individualized as well as multimodal approaches for future interventions.


  • Identity Formation and General and Cancer-specific Functioning in Adolescent and Emerging Adult Survivors of Childhood Cancer: A Longitudinal Study into Directionality of Effects

    by Janne Vanderhaegen, Sofie Prikken, Elise Van Laere, Jurgen Lemiere, Laurence Claes, Philip Moons, Anne Uyttebroeck, Sandra Jacobs, Koen Luyckx

    Background: Adolescent and emerging adult survivors of childhood cancer generally adjust well psychologically similar to their peers. Nevertheless, some survivors are at greater risk for developing psychological and physical difficulties. To shed light on the psychosocial functioning of adolescent and emerging adult survivors of childhood cancer, personal identity formation and its interplay with general and cancer-specific functioning need to be investigated. Purpose: To examine the longitudinal associations linking identity formation to general and cancer-specific functioning in adolescent and emerging adult childhood cancer survivors using three-wave data over a 2-year period. Methods: Dutch-speaking survivors (at baseline: n = 125; 53% female; age range: 14–25 years) treated at the pediatric oncology department of the University Hospitals Leuven (Belgium), completed self-report questionnaires at three annual timepoints. Directionality of effects and correlated changes were examined using cross-lagged structural equation modeling. Results: Regarding general functioning, bidirectional effects occurred. Life satisfaction positively predicted identity synthesis and both life satisfaction and good physical functioning negatively predicted identity confusion over time. Identity synthesis, in turn, positively predicted life satisfaction and identity confusion negatively predicted good physical functioning over time. Regarding cancer-specific functioning, mainly unidirectional effects occurred. Post-traumatic stress symptoms negatively predicted identity synthesis and positively predicted identity confusion over time, whereas the reverse pattern of associations was found for benefit finding. Several correlated changes were found linking identity formation and psychosocial functioning as well. Conclusions: The present study uncovered clinically meaningful pathways linking identity formation to psychosocial functioning over time in adolescents and emerging adults who survived childhood cancer.